Generalized anxiety disorder Trials in New York, United States
Conditions / Generalized anxiety disorder / New York, United States
Generalized anxiety disorder has been the subject of sustained clinical investigation across multiple research sites.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04751864 | Brain Stimulation & Generalized Anxiety Study | ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT00735267 | A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) | TERMINATED | PHASE3 |
| NCT00329264 | Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder | COMPLETED | PHASE3 |
| NCT06741228 | A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage) | ACTIVE_NOT_RECRUITING | — |
| NCT02256566 | Cognitive Training for Mood and Anxiety Disorders | COMPLETED | NA |
| NCT00730691 | Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder | COMPLETED | PHASE3 |
| NCT06741228 | A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage) | ACTIVE_NOT_RECRUITING | — |
| NCT00235508 | Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder | COMPLETED | PHASE4 |
| NCT06741228 | A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage) | ACTIVE_NOT_RECRUITING | — |
| NCT00329446 | Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder | COMPLETED | PHASE3 |